Ledger.Open graph →
SEC Form D · Amendment · filed July 28, 2025

ADvantage Therapeutics, Inc

Offering
$25.4M
Sold
$13.7M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
Miami, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Frank B. Mattner · Miami, FLDirectorDavid B. Buchsbaum · Miami, FLExecWalter B. Schmidt · Miami, FLDirectorAgustin B. Fernandez Santana Iii · Miami, FLExec · DirectorJeffrey B. Madden · Miami, FLExec · DirectorDaniel Abrams · New York, NYExecKevin Kreisler · VIRGINIA CITY, NVDirectorNicholas D. Lewin · NATICK, MADirectorOmar J. Ishrak · NATICK, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗